Gerresheimer new innovation SensAIR

Gerresheimer with innovative SensAIR platform for a drug delivery device for biologics

 Gerresheimer has developed SensAIR, an on-body drug delivery platform that can deliver drugs of higher viscosity, such as monoclonal antibodies (mAbs). The goal is to provide the best possible support for the subcutaneous administration of large-volume biologics. SensAIR allows patients to start medication on their own time in familiar surroundings, such as at home, with its easy-to-use On-Body Drug Delivery Device.

Follow us:

Share this article:

LinkedIn

Sign Up to our newsletter

Sign up to our newsletter to stay up to date with the latest industry news 

At Easyfairs, we take your privacy seriously and will only use the information we collect or receive about you in accordance with our privacy policy. If you change your mind you can unsubscribe at any time.